BGF MDI 320/14.4/9.6 μg clinical trials

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

This study is looking at a new inhaler for people with COPD who are also at risk of heart and lung problems. It compares a new 'triple therapy' inhaler with an existing one to see if it improves health outcomes for these individuals.